Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (11) , 1787-1792
- https://doi.org/10.1016/0006-2952(87)90239-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Analogues of RSU-1069: Radiosensitization and toxicity in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The phosphate-group of dna as a potential target for RSU-1069, a nitroimidazole-aziridine radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumorInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069British Journal of Cancer, 1986
- The differential cytotoxicity of RSU 1069: Cell survival studies indicating interaction with DNA as a possible mode of actionBritish Journal of Cancer, 1986
- RSU 1069, a nitroimidazole containing an aziridine groupBiochemical Pharmacology, 1986
- Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizerBiochemical Pharmacology, 1985
- Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069International Journal of Radiation Oncology*Biology*Physics, 1984
- RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivoBritish Journal of Cancer, 1984